Revive Therapeutics Slides 20% as Market Value Hits CAD 8.7 M and Liquidity Wanes
Revive Therapeutics slumps 20% as low liquidity, weak fundamentals and a shaky cannabinoid pipeline raise red flags for investors.
- REVIVE THERAPEUTICS LTD
- Canada
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read